0001225208-12-017361.txt : 20120807 0001225208-12-017361.hdr.sgml : 20120807 20120807160953 ACCESSION NUMBER: 0001225208-12-017361 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120807 FILED AS OF DATE: 20120807 DATE AS OF CHANGE: 20120807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clemmer James C CENTRAL INDEX KEY: 0001476700 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33259 FILM NUMBER: 121013339 MAIL ADDRESS: STREET 1: COVIDIEN PLC STREET 2: 15 HAMPSHIRE STREET CITY: MANSFIELD STATE: MA ZIP: 02048 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Covidien plc CENTRAL INDEX KEY: 0001385187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980624794 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 20 ON HATCH STREET 2: LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: DUBLIN 2 BUSINESS PHONE: 353 1 438-1700 MAIL ADDRESS: STREET 1: 20 ON HATCH STREET 2: LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: DUBLIN 2 FORMER COMPANY: FORMER CONFORMED NAME: Covidien Ltd. DATE OF NAME CHANGE: 20070321 FORMER COMPANY: FORMER CONFORMED NAME: Tyco Healthcare Ltd. DATE OF NAME CHANGE: 20070104 4 1 doc4.xml X0306 4 2012-08-07 0001385187 Covidien plc COV 0001476700 Clemmer James C C/O COVIDIEN 15 HAMPSHIRE STREET MANSFIELD MA 02048 1 Senior Vice President Ordinary Shares 2012-08-07 4 M 0 36000.0000 43.0878 A 66379.0000 D Ordinary Shares 2012-08-07 4 M 0 26106.0000 38.6485 A 92485.0000 D Ordinary Shares 2012-08-07 4 M 0 22717.0000 34.1500 A 115202.0000 D Ordinary Shares 2012-08-07 4 S 0 84823.0000 57.3029 D 30379.0000 D Stock Option (Right to Buy) 43.0878 2012-08-07 4 M 0 36000.0000 0.0000 D 2017-07-01 Ordinary Shares 36000.0000 0.0000 D Stock Option (Right to Buy) 38.6485 2012-08-07 4 M 0 26106.0000 0.0000 D 2016-11-20 Ordinary Shares 26106.0000 0.0000 D Stock Option (Right to Buy) 34.1500 2012-08-07 4 M 0 22717.0000 0.0000 D 2018-11-30 Ordinary Shares 22717.0000 7573.0000 D The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $57.30 to $57.36. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price. Fully exercisable. Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date. By: John W. Kapples, Attorney in Fact 2012-08-07